← Back to headlines
Tarsus Acquires iRenix Medical for $75 Million
Tarsus has completed the acquisition of iRenix Medical for $75 million, thereby gaining control of the late-stage eye care asset IRX-101.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Shein Shares Plunge on Hong Kong Stock Exchange Debut Amid Growth Concerns
18m ago
South Korea Reports Record August Export Surge Driven by Semiconductor Demand
21m ago
South Korean and Turkish Defense Firms Climb Global Industry Rankings
24m ago
Apple Accuses OpenAI of Misusing Confidential Data and Spoliating Evidence
29m ago